# Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence

> **NCT03108885** · — · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 11 (actual)

## Conditions studied

- Esophageal Neoplasm
- Esophageal Neoplasms Malignancy Unspecified
- Esophageal Neoplasms Malignant
- Cancer of Esophagus
- Cancer of the Esophagus
- Esophageal Cancer
- Esophagus Cancer
- Neoplasm, Esophageal

## Interventions

- **OTHER:** Blood and Tissue Collection

## Key facts

- **NCT ID:** NCT03108885
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-01
- **Primary completion:** 2020-05-25
- **Final completion:** 2020-05-25
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Study's Principal Investigator no longer at the institution.
- **Last updated:** 2024-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03108885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03108885, "Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03108885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*